Macquarie Group LTD Roivant Sciences Ltd. Transaction History
Macquarie Group LTD
- $85.1 Billion
- Q2 2024
A detailed history of Macquarie Group LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Macquarie Group LTD holds 3,180 shares of ROIV stock, worth $36,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,180Holding current value
$36,506% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$819 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$794 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$766 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$406 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$337 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.09B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...